the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Three more Malaysian hajj pilgrims die in Holy Land

MAKKAH: Three more Malaysian hajj pilgrims have died in the Holy Land, bringing the death toll to eight.

Minister in the Prime Minister’s Department Datuk Dr Mohd Na’aim Mokhtar said that the latest death, the eighth, involved a female pilgrim under the hajj pilgrimage operators (PJH) who passed away at 4.30pm on Saturday while walking back to her accommodation.

“The late Sabina Jalil, 66, from Sungai Buloh, Selangor, performed hajj with a friend and died due to a heart attack,” he told the media after visiting the TH Treatment Centre in Mina last night.

The sixth and seventh pilgrims who died were Baharuddin Mohd Shood, 75, from Jengka, Pahang, and Abd Manaf Hanapiah, 65, from Alor Setar, Kedah. They died on June 11 and June 13, respectively.

ALSO READ: Saudi Arabia begins enforcing penalties for performing hajj without permit

Baharuddin died of intestinal cancer at the TH Makkah Treatment Centre, while Abd Manaf died of a heart attack while receiving treatment at the Makkah Medical Centre.

Meanwhile, Mohd Na’im said that the patients being treated at the Treatment Centre in Makkah are those involved in the Wukuf Safari programme on Saturday, who were brought to Arafah by TH staff using a modified bus.

Most of them suffer from heart problems, in addition to health issues related to breathing difficulties.

The TH Treatment Centre in Makkah provides a total of 187 patient beds, complete with medical equipment, as well as x-ray services, emergency wards, dentistry, and laboratories, in addition to 17 ambulances serving 12 accommodation buildings for Malaysian pilgrims here.

ALSO READ: As pilgrims swelter, climate change looms over hajj

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings